Cutler Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $105K | Sell |
39,500
-275,100
| -87% | -$35.9M | 0.03% | 445 |
|
|
2023
Q4 | $549K | Buy |
314,600
+300,930
| +2,201% | +$23M | 0.05% | 394 |
|
|
2023
Q3 | $56K | Buy |
13,670
+5,025
| +58% | +$516K | 0.01% | 1443 |
|
|
2023
Q2 | $99K | Buy |
8,645
+3,170
| +58% | +$395K | 0.01% | 924 |
|
|
2023
Q1 | $28K | Sell |
5,475
-24,195
| -82% | -$3.28M | ﹤0.01% | 1723 |
|
|
2022
Q4 | $337K | Buy |
29,670
+12,220
| +70% | +$1.7M | 0.03% | 571 |
|
|
2022
Q3 | $265K | Sell |
17,450
-1,515
| -8% | -$278K | 0.02% | 824 |
|
|
2022
Q2 | $239K | Sell |
18,965
-1,620
| -8% | -$276K | 0.02% | 907 |
|
|
2022
Q1 | $343K | Sell |
20,585
-7,040
| -25% | -$2.65M | 0.02% | 853 |
|
|
2021
Q4 | $590K | Buy |
27,625
+17,745
| +180% | +$17M | 0.02% | 659 |
|
|
2021
Q3 | $320K | Sell |
9,880
-2,520
| -20% | -$3.1M | 0.01% | 1048 |
|
|
2021
Q2 | $1.23M | Buy |
12,400
+7,150
| +136% | +$9.92M | 0.06% | 377 |
|
|
2021
Q1 | $480K | Sell |
5,250
-115
| -2% | -$269K | 0.02% | 746 |
|
|
2020
Q4 | $1.98M | Sell |
5,365
-4,285
| -44% | -$6.83M | 0.09% | 213 |
|
|
2020
Q3 | $783K | Buy |
9,650
+6,800
| +239% | +$7.8M | 0.05% | 391 |
|
|
2020
Q2 | $563K | Buy |
2,850
+2,425
| +571% | +$2.1M | 0.04% | 458 |
|
|
2020
Q1 | $3K | Sell |
425
-5,850
| -93% | -$5.32M | ﹤0.01% | 3325 |
|
|
2019
Q4 | $645K | Sell |
6,275
-970
| -13% | -$870K | 0.04% | 367 |
|
|
2019
Q3 | $56K | Buy |
7,245
+1,630
| +29% | +$1.35M | 0.01% | 1449 |
|
|
2019
Q2 | $564K | Sell |
5,615
-15
| -0.3% | -$14.5K | 0.05% | 319 |
|
|
2019
Q1 | $412K | Buy |
5,630
+4,865
| +636% | +$5.06M | 0.04% | 379 |
|
|
2018
Q4 | $8K | Sell |
765
-1,100
| -59% | -$1.15M | ﹤0.01% | 2659 |
|
|
2018
Q3 | $176K | Buy |
1,865
+1,275
| +216% | +$2.5M | 0.01% | 905 |
|
|
2018
Q2 | $227K | Sell |
590
-260
| -31% | -$458K | 0.02% | 725 |
|
|
2018
Q1 | $281K | Sell |
850
-400
| -32% | -$745K | 0.02% | 643 |
|
|
2017
Q4 | $284K | Sell |
1,250
-700
| -36% | -$1.07M | 0.01% | 789 |
|
|
2017
Q3 | $397K | Sell |
1,950
-7,620
| -80% | -$10.6M | 0.01% | 770 |
|
|
2017
Q2 | $1.66M | Buy |
9,570
+5,260
| +122% | +$5.31M | 0.06% | 262 |
|
|
2017
Q1 | $307K | Buy |
4,310
+2,085
| +94% | +$1.86M | 0.01% | 895 |
|
|
2016
Q4 | $69K | Sell |
2,225
-6,235
| -74% | -$4.68M | ﹤0.01% | 2246 |
|
|
2016
Q3 | $1.3M | Buy |
8,460
+3,660
| +76% | +$3.02M | 0.06% | 241 |
|
|
2016
Q2 | $289K | Buy |
4,800
+1,190
| +33% | +$746K | 0.01% | 876 |
|
|
2016
Q1 | $85K | Buy |
3,610
+3,540
| +5,057% | +$2.24M | 0.01% | 1770 |
|
|
2015
Q4 | $9K | Buy |
+70
| New | +$113K | ﹤0.01% | 4260 |
|
Other funds holding LABU
TAA
TI
TRCT
GS
Cutler Group's LABU Position: Q1 2024 in Review
Cutler Group reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 99% in Q1 2024, selling an estimated $913K and leaving 66 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1377.
Cutler Group first reported a position in LABU in Q4 2015 and has held it in 26 quarters since. The position peaked at $5.7M in Q4 2021. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2024.
- Cutler Group held 66 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $8K as of Q1 2024.
- Cutler Group sold 6,995 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2024, an estimated $913K.
- Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1377 holding.
- Cutler Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2015 and has held it in 26 quarters since.
- Cutler Group's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $5.7M in Q4 2021.
- 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.